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Abstract
Background: We report the case of an adult patient with embryonal rhabdomyosarcoma of the perineum admitted
to our practice at Joliot Curie Institute in Dakar. It is a rare tumor at this age and has a bad prognosis at this localization.
Case presentation: We describe the case of a 22-year-old African man admitted for a perineal mass that had evolved
over 6 months. He complained of tenesmus, obstinate constipation, and dysuria. A clinical examination revealed
perineal swelling spread over his anus, scrotum, penis, testicles, and inguinal lymph nodes. A perineal ultrasound and
computed tomography scan showed a large mass driving his testicles forward with regional lymph node metastases.
An ultrasound-guided biopsy showed embryonal rhabdomyosarcoma on histology and immunohistochemistry, with
strong positivity of neural cell adhesion molecule and myogenin while results for cytokeratin AE1/AE3, cluster of
differentiation 45, synaptophysin, and chromogranin were negative. Our patient was classified T2N1M1. Outcome was
quickly marked by occlusive syndrome and colostomy. Our patient did not opt for chemotherapy and died after 6
months of follow-up.
Conclusions: The embryonic RMS of the adult is a rare disease. Despite the sensitivity to chemotherapy and surgery.
Localization to perineum remains poor prognosis.
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Background
Embryonal rhabdomyosarcoma (ERMS) is a rare type of
soft tissue tumor [1]. It predominates in children less than
7 years old while a second peak is observed in adoles-
cence; the two subtypes that affect both child and adult
are embryonal and alveolar rhabdomyosarcomas. A third
subtype, the pleomorphic RMS occurs almost exclusively
in adults [2]. The most common sites are cervical-cephalic
and genitourinary [3]. Perineal and anal localizations are
rarer and have worse prognosis [4].
We report the case of a 22-year-old patient with ERMS
of the perineum extended at the scrotum and penis with
inguinal lymph node involvement.
Case presentation
A 22-year-old African man without specific medical
history was admitted for a perineal mass evolving over
6 months, which was painful, and had appeared
spontaneously. An examination found tenesmus, ob-
stinate constipation, and dysuria. It revealed a dry peri-
neal swelling, which was painless, and extended back to
his anus, scrotum and penis. His testicles were mobile,
and there were enlarged and fixed lymphadenopathies
(Fig. 1).
A pelvic computed tomography (CT) scan found a large
mass on his perineum, fairly limited, driving his testicles for-
ward, with regional lymphadenopathies without secondary
lesion.
A pathological examination of the biopsy fragments taken
under ultrasound showed a tumor proliferation composed
of small-sized cell nuclei with an increase in the nucleocy-
toplasmic ratio, with a fairly monomorphic appearance and
associated with mitotic figures. These cells were disposed
around slots. Some cells had an eosinophilic cytoplasm
appearance (Fig. 2).
At immune marking, NCAM and myogenin (Figs. 3
and 4) were strongly positive, while CKAE1/AE3 anti-
body, CD45, synaptophysin, and chromogranin were* Correspondence: kasidy@hotmail.com
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negative. Our patient was classified T2N1M0 and then
considered as stage III.
Outcome was quickly marked by anal obstruction and
colostomy. He died after 6 months of follow-up with only
supportive care.
Discussion
Embryonal rhabdomyosarcoma is an extremely rare tumor
with an estimated incidence of 0.45 to 0.69 cases per
100,000. This case is the first case in more than 20,000
patients in our practice. The incidence of RMS in general,
and embryonic RMS especially, has a peak in young
children between 0 and 4 years. The incidence decreases
followed by another smaller peak between 15 and 19
years. After 19 years, the incidence decreases rapidly from
0.16 per 100,000 population between 20 and 24 years to
0.08 per 100,000 in the class of 25–29 years [1]. Definitive
diagnosis is based on histological examination. A surgical
biopsy is recommended. The needle biopsy is usually
reserved for small lesions located in areas to be treated
with radiation or chemotherapy or metastatic lesions [4].
The site of the lesion led us to a biopsy. CT and magnetic
resonance imaging (MRI) morphological examinations are
the most used in the expansion of the RMS balance sheet.
A CT scan is advantageous for evaluation of bone lesions
and abdominal lymphadenopathies. A MRI scan provides
a better definition of the primary tumor and its relations
with neighboring organs [4]. In our patient, CT was
sufficient to characterize the lesion and examine the locor-
egional extension.
Embryonal RMS generally has an intermediate progno-
sis [2]. However, perineal locations have the worst predic-
tions because they are usually diagnosed at a late stage [4].
The best prognostic factors in the perineal location are
stage I with small size, less than 5 cm, absence of nodal
involvement, and young age, less than 10 years [4]. The
Fig. 1 Dry whole perineal swelling with inguinal node involvement
Fig. 2 Increase in the nucleocytoplasmic ratio, monomorphic
appearance, and eosinophilic cytoplasm appearance
Fig. 3 NCAM- and myogenin-positive coloration - low magnification
Fig. 4 NCAM- and myogenin-positive coloration - high magnification
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histological type in this location does not seem to impact
overall survival [4].
The metastatic testicular damage in the ERMS has
been rarely described. Gow et al. [5] reported two cases
of metastatic testicular damage in ERMS in two young
subjects [5]. In the case of our patient it is unclear
whether the testicular damage was the result of contigu-
ity or rather the metastatic disease.
For our patient, a temporary colostomy was indicated;
it is often necessary in case of anal obstruction [4].
The oncological surgical treatment includes a complete
resection of the original site with a circumferential margin
of at least 0.5 cm [4]. In the anal and perineal locations,
difficulties stem from the vicinity of the anal sphincter,
urethra, and genitalia. In the case of our patient surgical
resection was not considered because of the anal, penile,
and scrotal involvement. Neoadjuvant chemotherapy
seemed to be the best alternative.
Nowadays, almost all patients with ERMS receive chemo-
therapy [4]. The most widely used protocol combines vin-
cristine, actinomycin D, and cyclophosphamide (VAC). New
protocols based on ifosfamide and etoposide were used in
combination with VAC in therapeutic trials with greater
local control and better survival at 3 years than VAC only.
These results suggest that the combination of ifosfamide-
etoposide and VAC could be beneficial for advanced ERMS
[6]. Other molecules such as irinotecan appear to be useful
in the treatment of advanced ERMS [7]. After resection or
biopsy, patients requiring radiotherapy are those having a
microscopic or macroscopic residue. For many patients,
radiation seems to be important to local disease control and
survival [4]. At this localization, embryonal rhabdomyosar-
coma seems to have better outcome than alveolar cases.
Anal infiltration and lymph node involvement, as in our
patient, are the main prognosis factors [8, 9].
Conclusions
We reported a case of embryonal RMS extended to the
perineum, scrotum, and penis with lymph node and testicu-
lar metastasis in 22-old-year African man. This is a rare
condition. Treatment is based on surgery, chemotherapy,
and radiotherapy, and prognosis depends on location and
regional extension. Death occurs in the case of extended
and nonresectable disease.
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